Publications by authors named "Myron Levin"

Claim this Profile
T
The recombinant zoster vaccine induces trained immunity in monocytes through persistent downregulation of TGFβ.
Michael J Johnson, Megan Crotteau, Debashis Ghosh, Thao Vu, Luke Trinity, Myron J Levin

PLoS Pathog· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Reduced Immunogenicity of Zoster Vaccines in CMV-Seropositive Older Adults Correlates with T Cell Imprinting.
Adriana Weinberg, Thao Vu, Michael J Johnson, D Scott Schmid, Myron J Levin

Vaccines (Basel)· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The economic rationale for cell-based influenza vaccines in children and adults: A review of cost-effectiveness analyses.
David Fisman, Norberto Giglio, Myron J Levin, Van Hung Nguyen, Stephen I Pelton

Hum Vaccin Immunother· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Absenteeism and Productivity Loss Due to Influenza or Influenza-like Illness in Adults in Europe and North America.
David Fisman, Maarten Postma, Myron J Levin, Joaquin Mould-Quevedo

Diseases· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Clinical and Economic Comparison of Cell-Based Versus Recombinant Influenza Vaccines in Adults 18-64 Years in the United States.
Myron J Levin, Neda Al Rawashdh, Liliane Mofor, Pablo Anaya, Richard M Zur

Vaccines (Basel)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trained Immunity Generated by the Recombinant Zoster Vaccine.
Adriana Weinberg, Michael Johnson, Megan Crotteau, Debashis Ghosh, Thao Vu, Myron J Levin

Res Sq· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, Safety, and Pharmacokinetics of AZD7442 (Tixagevimab/Cilgavimab) for Prevention of Symptomatic COVID-19: 15-Month Final Analysis of the PROVENT and STORM CHASER Trials.
Myron J Levin, Andrew Ustianowski, Stephane De Wit, Rohini Beavon, Jesse Thissen

Infect Dis Ther· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of high dose vitamin D supplementation on subsequent immune responses to administration of the live herpes zoster vaccine to long-term care residents.
Myron J Levin, Adit A Ginde, D Scott Schmid, Nancy Lang, Jennifer Canniff

Vaccine· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recruitment of naive CD4+ T cells by the recombinant zoster vaccine correlates with persistent immunity.
Kerry J Laing, Emily S Ford, Michael J Johnson, Myron J Levin, David M Koelle

J Clin Invest· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A clinical and economic assessment of adjuvanted trivalent versus standard egg-derived quadrivalent influenza vaccines among older adults in the United States during the 2018-19 and 2019-20 influenza seasons.
Myron J Levin, Victoria Divino, Maarten J Postma, Stephen I Pelton, Zifan Zhou

Expert Rev Vaccines· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Innate and Adaptive Cell-Mediated Immune Responses to a COVID-19 mRNA Vaccine in Young Children.
Adriana Weinberg, Michael J Johnson, Krystle Garth, Elena W Y Hsieh, Ross Kedl, Myron J Levin

Open Forum Infect Dis· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of 5-Year Persistence of Antibody Responses to Zoster Vaccines.
Adriana Weinberg, D Scott Schmid, Jessica Leung, Michael J Johnson, Congrong Miao, Myron J Levin

J Infect Dis· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breakthrough SARS-CoV-2 Infections in the PROVENT Prevention Trial Were Not Associated With AZD7442 (Tixagevimab/Cilgavimab) Resistant Variants.
Kevin M Tuffy, Bahar Ahani, Anastasia A Aksyuk, Miles Avila, Tyler Brady, Myron J Levin

J Infect Dis· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and clinical outcomes of pneumonia in persons with down syndrome in the United States.
Edward N Janoff, Hung-Fu Tseng, Jennifer L Nguyen, Tamuno Alfred, Jeffrey Vietri, Myron J Levin

Vaccine· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AZD7442 (Tixagevimab/Cilgavimab) for Post-Exposure Prophylaxis of Symptomatic Coronavirus Disease 2019.
Myron J Levin, Andrew Ustianowski, Steven Thomas, Alison Templeton, Yuan Yuan

Clin Infect Dis· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association Between Immunogenicity and Reactogenicity: A Post Hoc Analysis of 2 Phase 3 Studies With the Adjuvanted Recombinant Zoster Vaccine.
Andrea Callegaro, Wivine Burny, Caroline Hervé, Joon Hyung Kim, Myron J Levin

J Infect Dis· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Responses to Varicella-Zoster Virus Vaccines.
Myron J Levin, Adriana Weinberg

Curr Top Microbiol Immunol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of antibody-dependent cellular cytotoxicity in response to recombinant and live-attenuated herpes zoster vaccines.
Seong Yeon Park, Myron J Levin, Jennifer Canniff, Michael Johnson, D Scott Schmid

NPJ Vaccines· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of Severe Coronavirus Disease 2019 Disease in Individuals With Down Syndrome: A Matched Cohort Study From a Large, Integrated Health Care System.
Jennifer H Ku, Myron J Levin, Yi Luo, Ana Florea, I Chun Lin

J Infect Dis· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intramuscular AZD7442 (Tixagevimab-Cilgavimab) for Prevention of Covid-19.
Myron J Levin, Andrew Ustianowski, Stéphane De Wit, Odile Launay, Miles Avila, Dennis J Levinson

N Engl J Med· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell-Mediated Immune Responses After Administration of the Live or the Recombinant Zoster Vaccine: 5-Year Persistence.
Michael J Johnson, Cuining Liu, Debashis Ghosh, Nancy Lang, Myron J Levin

J Infect Dis· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Humoral and cellular immune responses to recombinant herpes zoster vaccine in patients with chronic lymphocytic leukemia and monoclonal B cell lymphocytosis.
Eli Muchtar, Amber B Koehler, Michael J Johnson, Kari G Rabe, Wei Ding, Myron J Levin

Am J Hematol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Real-World Clinical and Economic Analysis of Cell-Derived Quadrivalent Influenza Vaccine Compared to Standard Egg-Derived Quadrivalent Influenza Vaccines During the 2019-2020 Influenza Season in the United States.
Victoria Divino, Vamshi Ruthwik Anupindi, Mitch DeKoven, Joaquin Mould-Quevedo, Stephen I Pelton, Myron J Levin

Open Forum Infect Dis· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing the Clinical and Economic Outcomes Associated with Adjuvanted versus High-Dose Trivalent Influenza Vaccine among Adults Aged ≥ 65 Years in the US during the 2019-20 Influenza Season-A Retrospective Cohort Analysis.
Myron J Levin, Victoria Divino, Drishti Shah, Mitch DeKoven, Joaquin Mould-Quevedo

Vaccines (Basel)· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Antibody Responses to the Live-Attenuated and Recombinant Herpes Zoster Vaccines.
D Scott Schmid, Congrong Miao, Jessica Leung, Michael Johnson, Adriana Weinberg, Myron J Levin

J Virol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis